These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21186922)

  • 1. Brain potential indices of novelty processing are associated with preference for amphetamine.
    Gabbay FH; Duncan CC; McDonald CG
    Exp Clin Psychopharmacol; 2010 Dec; 18(6):470-88. PubMed ID: 21186922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acute effects of d-amphetamine and d-methamphetamine on ERP components in humans.
    Silber B; Croft R; Camfield DA; Downey LA; Papafotiou K; Stough C
    Eur Neuropsychopharmacol; 2012 Jul; 22(7):492-500. PubMed ID: 22209365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in auditory selective attention and event-related potentials following oral administration of D-amphetamine in humans.
    McKetin R; Ward PB; Catts SV; Mattick RP; Bell JR
    Neuropsychopharmacology; 1999 Sep; 21(3):380-90. PubMed ID: 10457535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.
    Makris AP; Rush CR; Frederich RC; Taylor AC; Kelly TH
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):123-33. PubMed ID: 17469936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of d-amphetamine in humans: influence of subclinical levels of inattention and hyperactivity.
    Sevak RJ; Stoops WW; Rush CR
    Am J Drug Alcohol Abuse; 2010 Jul; 36(4):220-7. PubMed ID: 20560842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Event-related potential study of novelty processing abnormalities in autism.
    Sokhadze E; Baruth J; Tasman A; Sears L; Mathai G; El-Baz A; Casanova MF
    Appl Psychophysiol Biofeedback; 2009 Mar; 34(1):37-51. PubMed ID: 19199028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of a new central adrenergic agonist--modafinil--and D-amphetamine on sleep and early morning behaviour in young healthy volunteers.
    Saletu B; Frey R; Krupka M; Anderer P; Grünberger J; Barbanoj MJ
    Int J Clin Pharmacol Res; 1989; 9(3):183-95. PubMed ID: 2568348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine choice prospectively predicts positive subjective effects of caffeine and d-amphetamine.
    Sigmon SC; Griffiths RR
    Drug Alcohol Depend; 2011 Nov; 118(2-3):341-8. PubMed ID: 21600707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in affect following amphetamine and placebo: markers of stimulant drug preference.
    Gabbay FH
    Exp Clin Psychopharmacol; 2003 Feb; 11(1):91-101. PubMed ID: 12622347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining task-dependencies of different attentional processes as reflected in the P3a and reorienting negativity components of the human event-related brain potential.
    Munka L; Berti S
    Neurosci Lett; 2006 Apr; 396(3):177-81. PubMed ID: 16356637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of an acute d-amphetamine administration on context information memory in healthy volunteers: evidence from a source memory task.
    Zeeuws I; Deroost N; Soetens E
    Hum Psychopharmacol; 2010; 25(4):326-34. PubMed ID: 20521323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subjective responses predict d-amphetamine choice in healthy volunteers.
    Murray CH; Li J; Weafer J; de Wit H
    Pharmacol Biochem Behav; 2021 May; 204():173158. PubMed ID: 33675838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personal significance is encoded automatically by the human brain: an event-related potential study with ringtones.
    Roye A; Jacobsen T; Schröger E
    Eur J Neurosci; 2007 Aug; 26(3):784-90. PubMed ID: 17634070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphetamine modulates human incentive processing.
    Knutson B; Bjork JM; Fong GW; Hommer D; Mattay VS; Weinberger DR
    Neuron; 2004 Jul; 43(2):261-9. PubMed ID: 15260961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acute nicotine on event-related potential and performance indices of auditory distraction in nonsmokers.
    Knott VJ; Bolton K; Heenan A; Shah D; Fisher DJ; Villeneuve C
    Nicotine Tob Res; 2009 May; 11(5):519-30. PubMed ID: 19380382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Amphetamine remediates attentional performance in rats with dorsal prefrontal lesions.
    Chudasama Y; Nathwani F; Robbins TW
    Behav Brain Res; 2005 Mar; 158(1):97-107. PubMed ID: 15680198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a new late positive ERP component in an attended novelty oddball task.
    McDonald CG; Gabbay FH; Rietschel JC; Duncan CC
    Psychophysiology; 2010 Sep; 47(5):809-13. PubMed ID: 20230498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.
    Lile JA; Stoops WW; Wagner FP; Glaser PE; Rush CR
    Pharmacol Biochem Behav; 2005 Oct; 82(2):270-9. PubMed ID: 16182353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Task switching and novelty processing activate a common neural network for cognitive control.
    Barcelo F; Escera C; Corral MJ; Periáñez JA
    J Cogn Neurosci; 2006 Oct; 18(10):1734-48. PubMed ID: 17014377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual differences in response to novelty, amphetamine-induced activity and drug discrimination in rats.
    Bevins RA; Klebaur JE; Bardo MT
    Behav Pharmacol; 1997 Jun; 8(2-3):113-23. PubMed ID: 9833007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.